top of page
A novel intraocular implant that preserves the capsular form and intracapsular space. An unmet challenge in replacement of the natural lens by an IOL, preventing optimisation of the visual outcome!
PCO, refractive surprise, Pseudophakic Dysphotopsia, IOL decentration and instability, anterior capsule phimosis, and PVD are the main associated complications.
PCO and Nd:YAG Capsulotomy
Refractive Error & Surprise
64% of patients implanted with a multifocal IOL are suffering from residual refractive error.²⁰
Loss of intracapsular volume and capsular fibrotic effects are complicating the replacement of an IOL.
Additional Complications
49% of patients will experience some aspect of dysphotopsia.²¹
0.21% to 1.40% incidence rate of capsular bag phimosis.²²
0.2% to 3% incidence rate of IOL dislocation.¹⁷⁻¹⁹
27.3% complete PVD with a 7-fold higher hazard risk ratio for progression to complete PVD.²³
A ground-breaking solution that defines a new era in cataract and refractive lens exchange surgery!
Shaped like a torus with a perfect balance of stability and flexibility, fixOflex™ is a medical implantable endocapsular device used during surgery prior to IOL implantation. It was designed to both fix the implanted IOL in its place and flex the empty capsule of the human crystalline lens to preserve its natural 3-D state and intracapsular volume. By doing so, it provides a platform that offers multitude of benefits.
2024
Initiation of official pediatric study
2012
Initial conception of the idea
2023
Completion of official clinical trials
2017
US Patent application
2019
Initiation of official clinical trials
2016
Initial peer reviewed publication
2020
US Patent application granted
2018
Establishment of Eye PCR B and worldwide patent application
2023
Worldwide patent application granted in various countries
Expecting CE Mark by mid 2024
2016
Initial peer reviewed publication
2018
Establishment of EYE PCR BV and worldwide patent application
2020
USA patent application granted
2023
Completion of official clinical trials
2012
Initial conception of the idea
2017
US Patent application
2019
Initiation of official clinical trials
2023
Worldwide patent application granted in various countries
2024
Initiation of official pediatric study
Expecting CE Mark by mid 2024
EYE PCR Showcases fixOflex Endocapsular Device at ESCRS Congress in Barcelona
EYE PCR’s fixOflex Technology to be Featured in “75th IOL Anniversary Experience” at ESCRS 2024
Another Interesting case from one of our users, whereby fixOflex was used to save the day
New indications for the application of fixOflex in vitreoretinal surgery
Healio presents on Occular Surgery News video from the ESCRS 2022 in Milan
Prof. Pallikaris on Fixoflex in IOL Implantation: Insights from ESCRS 2022
EYE PCR to Present at iNovation Day During ESCRS 2022 Annual Meeting
Eye PCR to Present Poster on fixOflex at ESCRS Milan 2022 and iNovation Symposium
fixOflex Selected to Present at Cataract Extraction Session
Dr. Ahmed Elmassry Presents fixOflex Implant Study at 2022 ARVO Annual Meeting
Prof. Pallikaris along with EYE PCR team at the 36th International Congress.
Dr. Santaro Noguchi Presents fixOflex Study Results at 45th Annual Meeting of Japanese Society of Ophthalmic Surgery
bottom of page